The document discusses how trade liberalization may impact public health in developing countries. It notes that while increased trade is often argued to promote growth and reduce poverty, thereby improving health, the evidence shows mixed results. Liberalization has increased economic insecurity and the trade of goods like tobacco, alcohol and unhealthy foods that harm health. Intellectual property rules in trade agreements also drive up drug costs and limit access to medicines in developing nations. The author argues trade agreements like Economic Partnership Agreements between the EU and African/Caribbean nations could negatively impact public health systems and access to affordable drugs.